repinotan hydrochloride has been researched along with Infarction, Middle Cerebral Artery in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horváth, E; Mauler, F | 1 |
Fahrig, T; Horváth, E; Jork, R; Mauler, F | 1 |
2 other study(ies) available for repinotan hydrochloride and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury.
Topics: Animals; Benzopyrans; Biomarkers; Brain; Brain Injuries; Hematoma, Subdural, Acute; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists; Stroke; Succinate Dehydrogenase; Thiazoles | 2005 |
Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.
Topics: Animals; Aspartic Acid; Benzopyrans; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Space; Glutamic Acid; Hippocampus; Infarction, Middle Cerebral Artery; Male; Microdialysis; Neuroprotective Agents; Organ Culture Techniques; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Synaptic Transmission; Thiazoles | 2001 |